RSS Feed

Guidelines for SSH Integration in mission-oriented research programmes

A new guideline gives practical advice on how to design and implement mission-oriented research programmes by integrating SSH from the start.

In November 2018, the Austrian Presidency organised a conference in Vienna discussing the impact of Social Sciences and Humanities (SSH) for a European research agenda. As a main result, the organisers of the conference under the lead of Thomas König, researcher at the Insitut für Höhere Studien in Vienna, have now published the document ‘Social Sciences and Humanities Research Matters. Guidelines on how to successfully design, and implement, mission-oriented research programmes’.

The document is aimed at all stakeholders dealing with research funding programmes and includes practical advice for the full exploitation of interdisciplinary cooperation to tackle societal challenges. Such societal challenges are often addressed in ‘mission-oriented’ research programmes setting out a specific goal. The guidelines urge stakeholders to move from an integration of SSH to full cooperation right from the design of a research funding programme all the way through to implementation. The authors give examples of actions that programme officers, reviewers and panellists or independent evaluators can use to take SSH research into account. The recommendations given in the guideline may apply to the design of new instruments within Horizon Europe, such as the missions.

For more information kindly refer to the European Commission's portal for Social sciences and humanities. 

Source: Swisscore

IMI2: New Call for proposals to be launched on 22 January! Sign up for webinars!

The Innovative Medicines Initiative (IMI2) will launch their next call for proposals, Call 17 on 22 Jan 2019. 

The following topics are under consideration for inclusion in this next IMI Call for proposals.

Optimising future obesity treatment
Open access chemogenomics library and chemical probes for the druggable genome
Intelligent prediction and identification of environmental risks posed by human medicinal products 

These topics are now at an advanced stage of development and these drafts shall allow potential applicants to start working actively on proposals and forming consortia. Nevertheless, these topics must still be approved by the IMI Governing Board. The final topic text may differ from the draft versions published, and applicants should always base their proposals on the final, approved topic texts which will be published when the Call is officially launched.

In preparation of this call, IMI-JU organises webinars from 23 to 31 January 2019.

All webinars on the Call topics will feature a presentation by the EFPIA topic coordinator and time for questions and answers. The webinars represent an excellent opportunity to learn more about the Call topics, interact directly with the topic coordinators, and get in touch with potential project partners.

The webinar on IMI’s rules and procedures will include presentations of IMI's intellectual property policy and tips on the preparation of proposal submissions. IMI will also hold a dedicated webinar for small and medium-sized enterprises (SMEs). This will cover elements of the different Call topics that may be of particular relevance for SMEs, as well as a presentation of IMI’s rules and procedures with a focus on aspects that are most important for SMEs.

Source: IMI-JU

Health EU CSA proposal successfully submitted!

We have successfully submitted the Health EU CSA proposal! 
  • With the ambitious unifying goal of empowering every citizen with a Human Avatar enabling access to comprehensive personalized healthcare, healthy lifestyle and disease prevention.
  • With a Consortium of 110 partners from 27 European countries, Canada and New Zealand, more than 75 stakeholders and hundreds of enthusiastic supporters across Europe.
  • With an International Advisory Board including 2 Nobel Laureates, several ex-Ministers of Health of EU countries and many international leaders and experts in Europe, USA, and Canada.
Many thanks to all the Consortium contributors, to the Strategic Board members and to Workpackage and Task Leaders, for their hard work and the outstanding product!
We are proud to be part of this endeavour!
For more information about this FET flagship proposal please refer to the Health EU website

Towards full open access: cOALition S

On 4 September 2018, a group of national research funding organisations, with the support of the European Commission and the European Research Council (ERC), announced the launch of cOAlition S, an initiative to make full and immediate Open Access to research publications a reality. It is built around Plan S, which consists of one target and 10 principles.
cOAlition S signals the commitment to implement, by 1 January 2020, the necessary measures to fulfil its main principle: By 2020 scientific publications that result from research funded by public grants provided by participating national and European research councils and funding bodies, must be published in compliant Open Access Journals or on compliant Open Access Platforms.”
Currently 12 national research funding organisations form cOAlition S and they have agreed to implement the 10 principles of Plan S in a coordinated way, together with the European Commission and the ERC. Other research funders from across the world, both public and private, are invited to join cOAlition S.
The initiative was born from the cooperation between the Heads of the participating Research Funding Organisations, Marc Schiltz the President of Science Europe, and Robert-Jan Smits the Open Access Envoy of the European Commission. It also drew on significant input from the Scientific Council of the ERC.
The research funders involved in cOAlition S will now collaborate with other stakeholders and work towards swift and practical implementation of these principles.
For more information about cOALition S and the "10 Principles of Plan S" please refer to the initiative's website
Source: Swisscore, Science Europe

Database on Funding Activities for Personalised Medicine (PM) Research Has Been Launched

The International Consortium for Personalised Medicine (ICPerMed) database, launched on 5 July 2018, gives an overview on the actions in the field of personalised medicine performed in the ICPerMed member states and may assist interested users in finding suitable funding opportunities and information about potential funders in their respective country and/or region.
The access to the data requires simple registration here.
The first ICPerMed Conference ‘Personalised Medicine in Action’ will take place on 20-21 November 2018 in Berlin, Germany. Registration is now open.
Sources: ICPerMed, Euresearch

The European Commission (EC) has published its proposal for the next European programme for research and innovation (2021-2027).

The "Horizon Europe’ programme (FP9) has a proposed budget of €94,1 billion and its structure is quite similar to the one of Horizon 2020. Concretely, the future programme is organised in three pillars, namely:

Pillar I: ‘Open Science’ [European Research Council (ERC), Marie-Slodowska Curie Actions (MSCA), Research Infrastructures] with a budget of €25,8 bn.
Pillar II: ‘Global Challenges and Industrial Competitiveness’ (five Clusters – Health; Inclusive and Secure Society; Digital and Industry; Climate, Energy and Mobility; Food and Natural Resources – and the Joint Research Centre) with a budget of €52,7 bn.
Pillar III: ‘Open Innovation’ [European Innovation Council (EIC), European Innovation Ecosystems, European Institute of Technology and Innovation (EIT)] with a budget of €13,5 bn.

For a summary of the new programme and a comparison with Horizon2020 please refer to related SwissCore news. To download the EC factsheets and legal texts please refer to the EC's information page.

Health EU – Human avatars to prevent and cure diseases: Proposal enters next stage of competition

The Health EU proposal is supported by the European Commission and has received an invitation from the European Commission to enter the next stage of the competition to become an EU Flagship for Future and Emerging Technologies.

Imagine a revolution in personalized healthcare and disease prevention system in Europe, based on human avatars of healthy individuals and patients for the prevention, interception and cure of disease. Nothing less is the aim of Health EU (healthy you!), an advanced FET Flagship multidisciplinary research initiative in Europe aiming for a paradigm shift to healthcare and for a future sustainable healthcare system.

SCIPROM is proud to be part of this consortium.

For more information about the project please refer to the Health EU website.

If you wish to be part of our Health EU Project or just to manifest your support to our idea, don't hesitate to contact us using our support form!

From Horizon 2020 to Horizon Europe

"It is hard to overestimate the importance of naming something. The very act itself captures hopes and expectations, and it marks the first step on the road to the future."

These thoughts were front of mind of the EC when deciding the new name for the ninth European framework programme for research and innovation, announced today: Horizon Europe.

"Horizon, because our brand means excellence. Over the past few years, the name "Horizon 2020" has sent a clear message across the globe: excellence. We have built a global reputation as a world leader in research and innovation programming, and it is for this reason that we believe the successor to Horizon 2020 should capitalise on this strong brand name. With Horizon Europe, we are enacting an evolution not a revolution. Building on the success of the past is putting our best foot forward for the future.

Europe, because we are proud of our collective strength. In Europe, as we face a period of poly-crises – economic, political and social – EU added value is important, now more than ever. Individually as Member States we are strong, but together as 27 our research and innovation potential is untold. The name "Horizon Europe" also speaks to our pride, because our Union is something we should be infinitely proud of. Too often we focus on the negative at a time when we should be celebrating our achievements. But with this new name we usher in an era of shouting about the EU as a success story.

Above all, by bestowing the name Horizon Europe on the next framework programme, we are bridging the past and the future of research and innovation in Europe. "

Source: Blog post Carlos Moedas

Switzerland and the SME instrument

Swiss SMEs continuously perform well! In the latest round of the SME Instrument phase 1, a total of 22 Swiss Small and medium-sized enterprises (SMEs) received funding. The European Commission (EC) received 2009 proposals and selected 257 Small and Medium-sized Enterprises (SMEs) that will receive €12.65 million in the latest round of the phase 1 SME instrument. Out of those 257, Switzerland is well represented with 22 SMEs receiving funding. The companies will receive a lump-sum of €50'000 to conduct a feasibility study. Moreover, they will receive 3 days of business coaching. Taking into account all the 10 cut-off rounds of the phase 1 SME instrument since Switzerland’s full participation in Horizon 2020 on 1 January 2017, 58 Swiss SMEs received in total €2.9 million. Only Spain, Italy and Israel have more SMEs that were selected. In the phase 2 of the SME instrument, which aims at financing more advanced innovation activities such as demonstration, testing, piloting and scaling up, only one Swiss company receive funding so far. A detailed overview about all the companies that were selected can be found in the recently launched EIC SME Instrument data hub. The next cut-off dates to apply for the next rounds of the SME instrument are 3 May 2018 for phase 1 and 23 May 2018 for phase 2.

Source: Swisscore

With Health EU, everyone will have an avatar to manage their health

What if everyone had their own medical avatar – a virtual replica of themselves featuring their own personal data – that could improve the way their health is managed and the way they are treated if they fall ill?

That is the bold proposal put forward by the Health EU project, whose tagline is “Human avatars to prevent and cure diseases”. This international project, led by a consortium headed by EPFL in collaboration with the Institute for Human Organ and Disease Model Technologies based in the Netherlands, recently applied to become a FET Flagship.

FET Flagship is a prestigious multi-disciplinary research programme run by the European Commission that offers €1 billion in funding over ten years.

SCIPROM is proud to be part of this consortium.

For more information about the project please refer to the Health EU website or the recent press release.

If you wish to be part of our Health EU Project or just to manifest your support to our idea, don't hesitate to contact us using our support form!

See Older Posts...